All > Alabama > Spokane

Difamilast Ointment 1% for Atopic Dermatitis

Phase-Based Progress Estimates
2
Effectiveness
3
Safety
Atopic DermatitisDifamilast - Drug
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This trial will evaluate the long-term safety and efficacy of difamilast ointment for treating atopic dermatitis in children.

Eligible Conditions
  • Atopic Dermatitis

Treatment Effectiveness

Effectiveness Progress

2 of 3
This is further along than 85% of similar trials

Similar Trials

1
FRTX-02 Capsule
1
S. hominis A 9 Product
1
ADX-914

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 52-week study period

52 week study period
The incidence and severity of treatment-emergent adverse events (TEAEs), serious adverse events (SAEs), and their relationship to study drug
52-week study period
Proportion of subjects who discontinue due to an AE over the study period

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Similar Trials

1
FRTX-02 Capsule
1
S. hominis A 9 Product
2
ADX-914

Trial Design

1 Treatment Group

Difamilast Ointment 1%
1 of 1

Experimental Treatment

500 Total Participants · 1 Treatment Group

Primary Treatment: Difamilast Ointment 1% · No Placebo Group · Phase 3

Difamilast Ointment 1%
Drug
Experimental Group · 1 Intervention: Difamilast · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 52-week study period

Who is running the clinical trial?

Acrotech Biopharma Inc.Lead Sponsor
29 Previous Clinical Trials
4,175 Total Patients Enrolled
Uma S Atmuri, MPharm MSStudy DirectorAcrotech Biopharma Inc.

Eligibility Criteria

Age Any Age · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Subjects who have an IGA of mild or moderate AD Severity and treatable body surface area (BSA) ≥3%at Baseline if not previously enrolled in study MEDI-MM36-301 OR b.
You are at least 2 years of age and either male or female.
Subjects who have a diagnosis of AD based on the American Academy of Dermatology AD diagnostic criteria.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top